Literature DB >> 8658160

A perspective on AIDS vaccines.

B R Bloom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8658160     DOI： 10.1126/science.272.5270.1888

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE.

Authors:  P Brown-Peterside; E Rivera; D Lucy; I Slaughter; L Ren; M A Chiasson; B A Koblin
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

2.  beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.

Authors:  J L Heeney; V J Teeuwsen; M van Gils; W M Bogers; C De Giuli Morghen; A Radaelli; S Barnett; B Morein; L Akerblom; Y Wang; T Lehner; D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

3.  Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

Authors:  P Brown-Peterside; M A Chiasson; L Ren; B A Koblin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

4.  Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.

Authors:  P Mooij; W M Bogers; H Oostermeijer; W Koornstra; P J Ten Haaft; B E Verstrepen; G Van Der Auwera; J L Heeney
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Low temperature and pressure stability of picornaviruses: implications for virus uncoating.

Authors:  A C Oliveira; D Ishimaru; R B Gonçalves; T J Smith; P Mason; D Sá-Carvalho; J L Silva
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

6.  Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.

Authors:  C A Van Baalen; M Schutten; R C Huisman; P H Boers; R A Gruters; A D Osterhaus
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.